Geneva, March 20 -- International Clinical Trials Registry received information related to the study (NCT07443020) titled 'Fast TILs to Treat Metastatic Pleural Effusions From Epithelial or Mesothelial Primary Tumors' on Feb. 25.

Study Type: Interventional

Study Design: Allocation: N/A. Intervention model: Single Group Assignment. Primary purpose: Treatment. Masking: None (Open Label).

Primary Sponsor: Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute)

Condition: Malignant Pleural Effusion Malignant Mesothelioma Pleural Effusion, Malignant Metastasis to Pleura

Intervention: Biological: locally manufactured adoptive cellular therapy (ACT) product

Recruitment Status: Not recruiting

Pha...